China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Up 32.8% in August

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) saw a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 53,900 shares, an increase of 32.8% from the August 15th total of 40,600 shares. Based on an average daily trading volume, of 627,300 shares, the short-interest ratio is presently 0.1 days. Approximately 1.6% of the shares of the company are short sold.

China SXT Pharmaceuticals Stock Performance

Shares of SXTC stock traded up $0.01 on Friday, hitting $0.67. 531,366 shares of the stock traded hands, compared to its average volume of 923,168. The company’s fifty day moving average is $0.94 and its 200 day moving average is $1.20. China SXT Pharmaceuticals has a 1-year low of $0.53 and a 1-year high of $6.39. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.51 and a current ratio of 1.60.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.